Phase I/II Study of AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin

Trial Profile

Phase I/II Study of AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Nov 2014

At a glance

  • Drugs Romiplostim (Primary) ; Carboplatin; Doxorubicin; Ifosfamide
  • Indications Thrombocytopenia
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top